Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose aildenafil citrate versus placebo pharmacodynamic and safety study in men with erectile dysfunction
ChiCTR1900026025Phase 2Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of aildenafil in erectile dysfunction (ED) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Duration of hardness greater than or equal to 60% during erection of the penile head and root. Started Jul 2018; status: recruiting.
02
Drugs
aildenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on ChiCTR1900026025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026025.